Defining the Future of the Stem Cell Industry: Interviews with Stem Cell Executives

Description

374 Page Interview Package
November 2018

As the world’s first and only market research firm to specialize in the stem cell industry, BioInformant has unrivaled access to stem cell industry executives. We used our connections to create this interview package featuring interviews with 54 leading stem cell executives.

Purpose:

Use this interview package to get an inside look into the future of the stem cell industry from the very people who are creating it.

Featured interviews include:

1. Interview with Kaz Hirao, CEO of Cellular Dynamics International (CDI), a FUJIFILM Company – Industrial Scale Manufacture of iPSC Cells and Differentiated Cell Types
2. Interview with Dr. Robert Hariri, CEO of Celularity (Part 1)- Big Bucks, Billionaire Investors, Bold Dreams
3. Interview with Dr. Robert Hariri, CEO of Celularity (Part 2)- Placental Stem Cell Spin-Out Celularity Raises $250M 
4. Interview with Dr. Ross Macdonald, CEO of Cynata Therapeutics – Creating the World’s First iPSC-Derived Therapeutic Product
5. Interview with Yaron Ramati, Director of Regulatory Affairs at Pluristem Therapeutics – An Expert’s Perspective on Accelerated Pathways for Cell Therapy Approvals
6. Interview with Dr. Yael Margolin, CEO of Gamida Cell – Solving the Unmet Need in Hematopoietic Stem Cell Transplantation (HSCT)
7. Interview with Dr. Riam Chammaa, Medical Director at the Canadian Centres for Regenerative Therapy (CCRT) – FDA Regulation of Cellular and Tissue-Based Products (HCT/Ps)
8. Interview with Yaky Yanay, President and COO of Pluristem Therapeutics – Commercializing Placental Stem Cell Therapeutics
9. Interview with Dr. Frida Grynspan, VP of Research & Development for Stem Cell Medicine, Ltd. – Developing Genetically Modified Muscle Progenitor Cells
10. Interview with Dr. Itzchak Angel, CEO of Accellta – Specializing in Mass Production of the Pluripotent Stem Cells
11. Interview with Eran Cohen, Accellta’s Intellectual Property (IP) Officer – A Small Company with the IP of a Big Company
12. Interview with Robin Smith, CEO of ORIG3N – Creating Patient-Specific iPSCs and a Living Database of Humanity
13. Interview with Dr. Cynthia Bamdad, CEO of Minerva Biotechnologies – The Link Between Naïve Stem Cells and Cancer
14. Interview with Matthew Feshbach, Founder of Okyanos Cell Therapy (Part 1) – Adipose-Derived Stem Cell Therapies
15. Interview with Matthew Feshbach, Founder of Okyanos Cell Therapy (Part 2) – Setting the Standard in Adipose-Derived Stem Cell Applications
16. Interview with Dr. Bruce Werber, COO of BPSR and CEO of Anu Life Sciences – Regenerative Applications of Placental Tissue Allografts
17. Interview with Dr. Ornella Parolini of IPLASS – The Rise of Placental Blood and Tissue Applications
18. Interview with Pamela Levin of Tisch MS Research Center of NY– Beginning a Phase II Stem Cell Trial for MS
19. Interview with Dr. Saud Sadiq, Director of the Tisch MS Research Center of NY – Stem Cells for Reversal of Multiple Sclerosis (MS)
20. Interview with James Alexis Mendez, CFO of CryoHoldco – Cord Blood Industry Consolidation within Latin America
21. Interview with Kenneth Harris, Chief Advisor for CuraSense Advisors – Growth Rates and Trends within the Cord Blood Industry
22. Interview with Joseph Krieger of Boston Biolife – Educating Physicians about Regenerative Medicine
23. Interview with James Lovgren, Business Development for ORIG3N – Creating World’s Largest Blood Cell Repository for iPSC Production
24. Interview with Tony Veverka, Chief Group Executive of BioEden – How Dental Stem Cells Will Impact Our Future
25. Interview with Joao Andrade, CEO of WideCells Group – Unlocking the Future of Cord Blood Banking
26. Interview with Dr. Jon Rowley, Founder and CTO of RoosterBio (2016) – Radically Changing the Use of Stem Cells
27. Interview with Dr. Jon Rowley, Founder and CTO of RoosterBio (2017) – “Year of the Rooster”
28. Interview with Dr. Paul Wotton, Board Member of Cynata Therapeutics and Previous CEO of Ocata Therapeutics – Mass Production of Therapeutic Grade MSCs 
29. Interview with Kyle Cetrulo, CEO of AuxoCell Laboratories – Future of Regenerative Medicine
30. Interview with Dr. Denver Lough, President and CEO of PolarityTE – Creating Functionally Polarized Tissue
31. Interview with Dr. Priya Baraniak of RoosterBio – RM Industry’s First Xeno-free (XF) hMSC Cell Banks
32. Interview with Dr. Chris Centeno, CEO of Regenexx®  (Part 1) – Orthopedic Applications of MSCs
33. Interview with Dr. Chris Centeno, CEO of Regenexx® (Part 2) – Visionary Behind Regenexx® Stem Cell Technology
34. Interview with Dr. Stefano Pluchino – How Exosomes Are Revolutionizing Neuroimmunology
35. Interview with David Sheehan, CEO of Nucleus Biologics – How Precision Cell Culture Can Enable Reproducible Science
36. Interview with Dr. Todd McAllister, Executive Director at the Amnion Foundation – Amniotic Stem Cells: An Extension of the Cord Blood Banking Model
37. Interview with Dr. Abhijit Bopardikar, Director of ReeLabs – Cord Blood Banking in India
38. Interview with Patrick Dentinger, CEO of Absorption Systems – Advances with in vitro Science are Translating to Human Outcomes 
39. Interview with Kyle Cetrulo, Founder of the Perinatal Stem Cell Society – Current and Future Landscape of Perinatal Stem Cells 
40. Interview with Dr. Paul Slowey of Oasis Diagnostics – Salivary EVs, Exosomes, and the Future of Non-Invasive Diagnostics
41. Interview with Dr. Chen-Tsai, CEO of Applied StemCell – New Frontiers in Gene-Editing and Stem Cell Innovation
42. Interview with Dr. Denver Lough, President and CEO of PolarityTE – Advancing Regenerative Medicine with Functionally Polarized Tissue Substrates
43. Interview with Mayur Srisimal, CEO of LifeCell – Regenerative Medicine Applications of Cord Blood and Tissue in India
44. Interview with Bernard Siegal of the Regenerative Medicine Foundation (RMF) – The Making of a Stem Cell Super-Ecosystem 
45. Interview with Gary Harlem, CEO of AltuCell – Reversing Type I Diabetes with Encapsulated Cell Therapy Technology
46. Interview with Dr. Jay Tong, CEO of AllCells – Breakthrough Solutions for Human Primary Cells & Hematologic Tissue Products
47. Interview with Jim McGorry, CEO of Biostage, Inc. – Inside Scoop on Biostage, a World Leader in Bioengineered Organs
48. Interview with Troels Jordansen, CEO of Glycostem – Will Glycostem Release 1st Allogeneic NK Cell Product with Off-the-Shelf Potential?
49. Interview with Dr. Milano of Fred Hutchinson Cancer Research Centre  – Trends in Umbilical Cord Blood and Tissue Banking
50. Interview with Alec Lee, Business Development at Extem Bioscience – Improving Access to Donor- and Disease-Specific Stem Cells
51. Interview with Dr. Askenase, Yale University School of Medicine – Role of MSC-Derived Exosomes in Healing the Injured Spinal Cord – Interview  – 
52. Interview with Bobby Ardila, V.P. of International Medical Communications for Neo Matrix, LLC – Use of Placental Tissue Matrix for Regenerative Medicine Applications
53. Interview with Gregory Block, VP of Business Development for Universal Cells – Will Universal Cell’s Gene-Editing Tech Create Universally Compatible Stem Cells?
54. Interview with Dr. Racheli Ofir, VP of Research & IP at Pluristem Therapeutics – Leveraging Placental Cells and 3D Manufacturing Technology (Bioreactors) 

DELIVERY: Claim this report now to get immediate download on any device, with printing rights allowed.

For a limited-time, you can access it for 50% off (only $97).

Of course, your investment is backed by our 60-Day Money Back Guarantee.